Macquarie Group LTD Ardelyx, Inc. Transaction History
Macquarie Group LTD
- $83.5 Billion
- Q3 2025
A detailed history of Macquarie Group LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 10,455,588 shares of ARDX stock, worth $61.4 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,455,588
Previous 11,457,557
8.75%
Holding current value
$61.4 Million
Previous $44.9 Million
28.5%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding ARDX
# of Institutions
244Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
-
Marshall Wace, LLP London, X08.94MShares$52.5 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...